Renaissance Group LLC Gilead Sciences, Inc. Transaction History

Renaissance Group LLC

$2.36 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $22,574 - $25,749	297 Added 9.06%	3,575 $275,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $17,703 - $20,170	-229 Reduced 6.53%	3,278 $271,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $14,769 - $21,204	-237 Reduced 6.33%	3,507 $301,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $216,103 - $243,397	3,744 New	3,744 $231,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $197,645 - $215,955	-3,114 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $186,840 - $213,184	3,114 New	3,114 $201,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $627,682 - $715,214	-11,080 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $102,216 - $128,519	-1,646 Reduced 12.93%	11,080 $700,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $23.4 Million - $27.1 Million	-323,120 Reduced 96.21%	12,726 $979,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $18,162 - $23,263	290 Added 0.09%	335,846 $25.1 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.31 Million - $1.44 Million	-21,185 Reduced 5.94%	335,556 $21.8 Million
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $502,017 - $554,139	8,031 Added 2.3%	356,741 $22.6 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $975,937 - $1.09 Million	15,774 Added 4.74%	348,710 $23.6 Million
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $566,209 - $634,302	9,055 Added 2.8%	332,936 $21.6 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $2.38 Million - $3.1 Million	-39,251 Reduced 10.81%	323,881 $20.3 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $750,649 - $831,106	-10,531 Reduced 2.82%	363,132 $28 Million
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $562,769 - $656,448	-8,674 Reduced 2.27%	373,663 $26.5 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $349,194 - $425,707	-4,794 Reduced 1.24%	382,337 $28.8 Million
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $1.05 Million - $1.23 Million	-14,705 Reduced 3.66%	387,131 $27.7 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $29 Million - $34.3 Million	401,836	401,836 $32.6 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.

Account